SCHEMBL311402

SCHEMBL311402

CCOC(=O)Cc1cc(O)ccc1-c1cc(=O)c2c(O)cccc2o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.53
AR P10275 9/20 0.50
CYP3A4 P08684 5/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
MAPT P10636 4/20 0.50
HPGD P15428 2/20 0.50
MAPK1 P28482 2/20 0.50
POLH Q9Y253 2/20 0.50
RAF1 P04049 1/20 0.50
TYR P14679 1/20 0.47
PTPN1 P18031 1/20 0.47
PTGS1 P23219 1/20 0.47
BACE1 P56817 1/20 0.47
PTPN12 Q05209 1/20 0.47
PTPN22 Q9Y2R2 1/20 0.47
ALOX15 P16050 2/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312442 0.89 BACE1 (0.62) ATMARCYP3A4MEN1KMT2A
SCHEMBL311334 0.87 EGFR (0.46) KMT2AMAPTHPGDMAPK1POLH
SCHEMBL311962 0.86 EGFR (0.47) MEN1KMT2AMAPTHPGDPOLH
SCHEMBL10215485 0.86 HPGD (0.59) CYP3A4MEN1KMT2AMAPTHPGD
SCHEMBL311828 0.84 CYP2D6 (0.46) CYP3A4MEN1KMT2AMAPTHPGD
SCHEMBL312252 0.84 AKR1B1 (0.46) CYP3A4MEN1KMT2AMAPTHPGD
SCHEMBL312410 0.84 CYP3A4 (0.52) CYP3A4MEN1KMT2AMAPTHPGD
SCHEMBL312740 0.84 AKR1B1 (0.57) CYP3A4MEN1KMT2AHPGDMAPK1
SCHEMBL311888 0.81 ATM (0.53) ATMARCYP3A4MEN1KMT2A
SCHEMBL313004 0.80 ATM (0.52) ATMARCYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed